跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
solid tumor therapeutic
首页
药物
solid tumor therapeutic
solid tumor therapeutic
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Lipid formulations for nucleic acid delivery
US 8283333 B2
申请人: YAWORSKI ED
优先权: 2009
EP
US
WO
16 件公开
Isolation and use of solid tumor stem cells
US 6984522 B2
申请人: UNIV MICHIGAN
优先权: 2001
US
12 件公开
INNATE TARGETING OF ADOPTIVE CELLULAR THERAPIES
EP 3735265 A4
申请人: QU BIOLOGICS INC
优先权: 2018
CN
EP
US
WO
6 件公开
Reagents and methods for cancer treatment and prevention
US 9107863 B2
申请人: NIAZI KAYVAN R
优先权: 2006
CN
US
6 件公开
Compositions and methods for combination therapy with dengue virus and dendritic cells
US 9730989 B2
申请人: PRIMEVAX IMMUNO-ONCOLOGY INC
优先权: 2015
CN
US
6 件公开
Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy
US 7125541 B2
申请人: UNIV TEXAS
优先权: 2000
US
5 件公开
PERIOPERATIVE INNATE IMMUNE PRIMING IN CANCER THERAPY
EP 4313176 A1
申请人: QU BIOLOGICS INC
优先权: 2021
EP
US
WO
4 件公开
Methods and compositions for liquidation of tumors
US 2011142887 A1
申请人: IMMUNOVATIVE THERAPIES LTD
优先权: 2009
CN
US
4 件公开
Combination therapy for cancer treatment
US 9895365 B2
申请人: IPSEN BIOPHARM LTD
优先权: 2015
CN
US
4 件公开
NOVEL COMPOSITIONS AND USES OF ANTI-HYPERTENSION AGENTS FOR CANCER THERAPY
EP 2640359 A4
申请人: GEN HOSPITAL CORP
优先权: 2010
CN
EP
WO
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈